Status:
COMPLETED
Auditory-Cognitive Dual-Task Intervention for Older Adults With Hearing Loss
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Age-related Hearing Loss
Cognitive Decline
Eligibility:
All Genders
60-100 years
Phase:
NA
Brief Summary
Background: Age-related hearing loss (ARHL) is a common and irreversible condition that has been recently associated with cognitive decline and dementia. Hence, if ARHL is treated earlier, the risk of...
Eligibility Criteria
Inclusion
- aged 60 and above living in the community;
- have mild to moderate hearing loss with a pure-tone average (PTA) between 25 and 60 dB in both ears (average hearing threshold at 0.5, 1, 2, and 4 kHz measuring by audiometer with headphones in a quite listening environment, no hearing aid use within the past 6 months;
- with normal cognitive performance (MoCA score ≥26); and
- are willing to and capable of providing informed consent and complying with study procedures.
Exclusion
- have a history of psychosis, mania, bipolar disorder, substance use disorder or have current suicidal ideation;
- with severe or unstable medical illness, significant retrocochlear pathology or organic lesion responsible for hearing loss;
- a diagnosis of probable Alzheimer's disease, vascular dementia, FTD, or Parkinson's Disease; and
- taking medications such as antidepressants, sedatives, or antiepileptics that may affect cognition.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06486285
Start Date
August 1 2024
End Date
July 1 2025
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PolyU
Hong Kong, Hong Kong